A Retrospective Study of the Impact of 21-Gene Recurrence Score Assay on Treatment Choice in Node Positive Micrometastatic Breast Cancer

by Thomas G. Frazier, Kevin R. Fox, J. Stanley Smith, Christine Laronga, Anita McSwain, Devchand Paul, Michael Schultz, Joseph Stilwill, Christine Teal, Tracey Weisberg, Judith F. Vacchino, Amy P. Sing, Dasha Cherepanov, Wendy Hsiao, Eunice Chang, Michael S. Broder
Published 2015-03-01